“Starting next year, American drug prices will come down fast and furious and will soon be the lowest in the developed world,” President Donald Trump claimed Friday as the White House announced agreements with nine pharmaceutical manufacturers. The administration struck most favored nation (MFN) pricing deals with Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences…
This post has been syndicated from Truthout, where it was published under this address.